These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 873132)

  • 1. Increased sulfation and decreased 7alpha-hydroxylation of deoxycholic acid in ethinyl estradiol-induced cholestasis in rats.
    Jensen RT; Davis RA; Kern F
    Gastroenterology; 1977 Aug; 73(2):314-20. PubMed ID: 873132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ethinyl estradiol and phenobarbital on bile acid synthesis and biliary bile acid and cholesterol excretion.
    Davis RA; Kern F
    Gastroenterology; 1976 Jun; 70(6):1130-5. PubMed ID: 1269874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte taurocholic acid uptake in the regression of ethinyl estradiol cholestasis. Preliminary results.
    Chiarantini E
    Boll Soc Ital Biol Sper; 1984 Mar; 60(3):523-7. PubMed ID: 6712817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zonal changes of hepatobiliary taurocholate transport in intrahepatic cholestasis induced by 17 alpha-ethinyl estradiol: a histoautoradiographic study in rats.
    Buscher HP; Meder I; MacNelly S; Gerok W
    Hepatology; 1993 Mar; 17(3):494-9. PubMed ID: 8444423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cholestasis on hepatic transport of 99mtechnetium p-isopropyl-iminodiacetic acid.
    Knodell RG; Shafer RB; Stanley LN; Goodman M; Elson MK
    J Lab Clin Med; 1984 Oct; 104(4):517-27. PubMed ID: 6481215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid metabolism in cirrhosis. IV. Characterization of the abnormality in deoxycholic acid metabolism.
    Yoshida T; McCormick WC; Swell L; Vlahcevic ZR
    Gastroenterology; 1975 Feb; 68(2):335-41. PubMed ID: 1116679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of ethinyl estradiol-induced bile secretory failure with Triton WR-1339.
    Simon FR; Gonzalez M; Sutherland E; Accatino L; Davis RA
    J Clin Invest; 1980 Apr; 65(4):851-60. PubMed ID: 6244335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
    Clerici C; Castellani D; Asciutti S; Pellicciari R; Setchell KD; O'Connell NC; Sadeghpour B; Camaioni E; Fiorucci S; Renga B; Nardi E; Sabatino G; Clementi M; Giuliano V; Baldoni M; Orlandi S; Mazzocchi A; Morelli A; Morelli O
    Toxicol Appl Pharmacol; 2006 Jul; 214(2):199-208. PubMed ID: 16487557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of liver plasma membrane fluidity in the pathogenesis of estrogen-induced cholestasis.
    Smith DJ; Gordon ER
    J Lab Clin Med; 1988 Dec; 112(6):679-85. PubMed ID: 3193023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic handling of bile salts and protein in the rat during intrahepatic cholestasis.
    Goldsmith MA; Huling S; Jones AL
    Gastroenterology; 1983 May; 84(5 Pt 1):978-86. PubMed ID: 6832571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of diosgenin, a plant-derived steroid, on bile secretion and hepatocellular cholestasis induced by estrogens in the rat.
    Accatino L; Pizarro M; Solís N; Koenig CS
    Hepatology; 1998 Jul; 28(1):129-40. PubMed ID: 9657105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat.
    El-Mir MY; Monte MJ; Morales AI; Arevalo M; Serrano MA; Marin JJ
    Hepatology; 1997 Sep; 26(3):527-36. PubMed ID: 9303479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
    Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
    Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of estradiol and ethinyl estradiol on biliary bile acid excretion and bile flow].
    Reimold WV; Holtermann M
    Med Welt; 1982 Dec; 33(48):1744-8. PubMed ID: 7154929
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversible impairment of neonatal hepatobiliary function by maternal cholestasis.
    Monte MJ; Morales AI; Arevalo M; Alvaro I; Macias RI; Marin JJ
    Hepatology; 1996 May; 23(5):1208-17. PubMed ID: 8621155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No increase of biliary permeability in ethinylestradiol-treated rats.
    Jaeschke H; Krell H; Pfaff E
    Gastroenterology; 1983 Oct; 85(4):808-14. PubMed ID: 6884706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone-induced bile flow and hepatobiliary calcium fluxes are attenuated in the perfused liver of rats made cholestatic with ethynylestradiol in vivo and with phalloidin in vitro.
    Hamada Y; Karjalainen A; Bygrave FL
    Hepatology; 1995 May; 21(5):1455-64. PubMed ID: 7737653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactosamine prevents ethinylestradiol-induced cholestasis.
    Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Mottino AD; Pozzi EJ
    Drug Metab Dispos; 2006 Jun; 34(6):993-7. PubMed ID: 16554370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced cholestatic potency of taurolithocholate during backward perfusion of the rat liver.
    Baumgartner U; Hardison WG; Miyai K
    Lab Invest; 1987 Jun; 56(6):576-82. PubMed ID: 3599905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat.
    Crocenzi FA; D'Andrea V; Catania VA; Luquita MG; Pellegrino JM; Ochoa JE; Mottino AD; Sánchez Pozzi EJ
    Drug Metab Dispos; 2005 Jul; 33(7):888-91. PubMed ID: 15843489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.